Bogdan Gologan

Bogdan Gologan, Ph.D., is an experienced professional in analytical development and operations, currently serving as Associate Director of Analytical Development/Analytical Strategy and Operations at Bristol-Myers Squibb. Gologan's career includes roles as Principal at DTR Consortium, Managing Director and Investor at Golden Seeds, and Director of Analytical Operations for Manufacturing and R&D at Edge Therapeutics, Inc. Additionally, Gologan held the position of QA Lab Manager for the Lutonix Division at CR Bard. Academic credentials include a Ph.D. in Analytical Chemistry from Purdue University and an M.S. in Industrial Chemistry from the University of Central Florida.